Instil Bio, Inc.
TIL
$11.49
$0.716.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.49% | 24.13% | -137.07% | 48.33% | -54.33% |
| Total Depreciation and Amortization | 0.00% | -97.59% | -32.79% | -17.76% | -7.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.44% | -41.48% | 325.96% | -58.74% | 159.94% |
| Change in Net Operating Assets | 114.68% | -239.49% | 188.83% | 56.33% | -811.83% |
| Cash from Operations | 28.63% | -252.59% | 60.27% | 47.55% | -89.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -61.54% | -96.79% | 26.56% | 6,300.00% | -99.08% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,144.07% | -104.49% | -27.40% | -35.99% | 74.13% |
| Cash from Investing | 2,211.75% | -104.16% | -26.07% | -34.39% | 66.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 432.39% | -82.43% | 96.12% | 29.56% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 3,943.60% | 87.46% | -- | -- |
| Cash from Financing | -94.34% | 2,780.17% | -85.46% | 903.77% | -- |
| Foreign Exchange rate Adjustments | -219.05% | -51.16% | 166.15% | -254.76% | 625.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.30% | -249.15% | 43.28% | 3,466.10% | -109.10% |